SCHEMBL10670231

SCHEMBL10670231

Cc1c(-c2cc(Br)c(O)c(Br)c2)oc2cc(OP(=O)(O)O)ccc2c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 7/20 0.46
▸ ALDH1A1 P00352 5/20 0.46
▸ CYP2C9 P11712 3/20 0.46
▸ CYP2C19 P33261 3/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ KMT2A Q03164 6/20 0.46
▸ KDM4E B2RXH2 6/20 0.46
▸ MEN1 O00255 5/20 0.46
▸ HSD17B10 Q99714 5/20 0.46
▸ MAPT P10636 4/20 0.46
▸ HPGD P15428 3/20 0.46
▸ CASP1 P29466 3/20 0.46
▸ CASP7 P55210 3/20 0.46
▸ TP53 P04637 2/20 0.46
▸ STS P08842 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.42
▸ ABCG2 Q9UNQ0 2/20 0.42
▸ ACHE P22303 1/20 0.40
▸ BACE1 P56817 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10669999 0.91 KMT2A (0.45) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL10756892 0.82 ALDH1A1 (0.46) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL10516555 0.81 ALDH1A1 (0.69) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL10671037 0.78 ALOX5 (0.40) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL10666554 0.77 ALDH1A1 (0.39) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL1447424 0.73 MAPT (0.56) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL10753926 0.73 KMT2A (0.45) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL10515926 0.70 CYP3A4 (0.54) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL10516653 0.69 ALDH1A1 (0.66) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL140039 0.69 ALDH1A1 (0.66) ALDH1A1CYP2C9TDP1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4788215-A TREATMENT OF HYPERTHYROIDISM MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1988-11-29 — — US disclosed
US-4713465-A Flavanone intermediates for halogenohydroxyflavones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-12-15 — — US disclosed
Send feedback